Roggwil, February 28, 2022 – As already announced in January 2022, the expansion of the production of the tinniwell is being worked on at full speed. The production of the tinniwell will start this week at another contract manufacturer. The background is to ensure patient care with the tinniwell. After delivery of this series, a framework agreement is sought to produce further 2,000 devices from this manufacturer.
++ About Resaphene Suisse AG
Resaphene Suisse AG, based in Roggwil, Switzerland, is a medical technology company that was founded in 2015 and has been selling a tinnitus therapy device under the name tinniwell since 2016.
++ Contact for questions:
Resaphene Suisse AG
Mrs. Anke Rauterkus (Chief Executive Officer)
T. +41 714500668